Avecho BiotechnologyAVEFF -74.14% Market Cap is $55.93 Mil as of Jul. 06, 2026. The stock has 2 warning signs investors should review. Among 1,422 Biotechnology companies, Avecho Biotechnology ranks worse than 60.27% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Avecho Biotechnology's share price for the quarter that ended in Dec. 2025 was $0.0045. Avecho Biotechnology's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 3,673.46 Mil. Therefore, Avecho Biotechnology's market cap for the quarter that ended in Dec. 2025 was $16.53 Mil.
Avecho Biotechnology's quarterly market cap
increased
from Dec. 2024 ($3.80 Mil) to Jun. 2025 ($14.28 Mil) and
increased
from Jun. 2025 ($14.28 Mil) to Dec. 2025 ($16.53 Mil).
Avecho Biotechnology's annual market cap
increased
from Dec. 2023 ($0.63 Mil) to Dec. 2024 ($3.80 Mil) and
increased
from Dec. 2024 ($3.80 Mil) to Dec. 2025 ($16.53 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Avecho Biotechnology's Enterprise Value for Today is $52.72 Mil.
Avecho Biotechnology (OTCPK:AVEFF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Avecho Biotechnology Market Cap Related Terms
Avecho Biotechnology Market Cap Historical Data
* Premium members only.
The historical data trend for Avecho Biotechnology's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Avecho Biotechnology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avecho Biotechnology Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's Market Cap distribution charts can be found below:
* The bar in red indicates where Avecho Biotechnology's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Avecho Biotechnology's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avecho Biotechnology (AVEFF) has a Market Cap of $55.93 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Avecho Biotechnology and its competitors. According to the industry distribution chart, Avecho Biotechnology ranks #857 out of 1422 companies in the Biotechnology industry, placing it in the top 60.3%.
Is Avecho Biotechnology's Market Cap too high?
Avecho Biotechnology's current Market Cap is $55.93 Mil. The Biotechnology industry median Market Cap is 120.73. Avecho Biotechnology's value of $55.93 Mil is 53.7% below this industry median. Based on the distribution chart, Avecho Biotechnology ranks #857 out of 1422 companies in the Biotechnology industry, which is below the industry midpoint.
How does Avecho Biotechnology's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Avecho Biotechnology ranks #857 out of 1422 companies for Market Cap. This places Avecho Biotechnology in the lower half of its industry. The industry median Market Cap is 120.73. Avecho Biotechnology's value of $55.93 Mil is 53.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 120.73, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avecho Biotechnology's current Market Cap of $55.93 Mil is 53.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Avecho Biotechnology and its competitors. For the Biotechnology industry, the median Market Cap is 120.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avecho Biotechnology's current Market Cap is $55.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (AVEFF) has a current Market Cap of $55.93 Mil. The current Market Cap is $55.93 Mil and 53.7% below the Biotechnology industry median of 120.73. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Avecho Biotechnology (AVEFF), the current Market Cap is $55.93 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVEFF has been successfully added to your 